Batavia Biosciences

About:

Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product

Website: http://www.bataviabiosciences.com/

Twitter/X: Batavia_BS

Top Investors: Bill & Melinda Gates Foundation, National Institute for Innovation in Manufacturing Biopharmaceuticals

Description:

Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost. Our services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. Batavia Biosciences has successfully worked on viral and bacterial vaccines, recombinant proteins, antibodies and gene therapy products. Unique technologies such as STEP® protein expression technology and SCOUT® high throughput process technology accelerate timelines and reduce costs.

Total Funding Amount:

$8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Leiden, Zuid-Holland, The Netherlands

Founded Date:

2010-01-01

Contact Email:

info(AT)bataviabiosciences.com

Founders:

Christopher Yallop, Menzo Havenga

Number of Employees:

101-250

Last Funding Date:

2024-04-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai